Generic Drugs Regulations and Registration in Indonesia, Malaysia and Vietnam: A Drug Regulatory Case Study
1★, 1, 1, 2★ Corresponding author
- 1Department of Pharmaceutical Regulatory Affairs, NGSM Institute of Pharmaceutical Sciences, NITTE (Deemed to be University), Deralakatte, Mangaluru, Karnataka, INDIA.
- 2Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, SS Nagara, Mysuru, Karnataka, INDIA.
CORRESPONDENCE
Sandeep DS
Department of Pharmaceutical Regulatory Affairs, NGSM Institute of Pharmaceutical Sciences, NITTE (Deemed to be University), Deralakatte, Mangaluru, Karnataka, INDIA.
Received: 30-10-2021; Revised: 05-12-2021; Accepted: 20-12-2021.
Volume 14, Issue 1 · pp. 33-36 · 2022 · DOI: 10.5530/jyp.2022.14.7
ABSTRACT
Objectives: The present study describes the generic drug regulations and registration process in three ASEAN countries Indonesia, Malaysia and Vietnam.Methods: For the current study, the information has been taken from guidelines set forth by the respective regulatory authorities of three selected ASEAN countries concerning the technical guidelines available for generic drugs. Relevant data were also collected from regulatory websites and articles from reputed journals.Results: The process of site evaluation, pre-submission, dossier screening, registration and regulatory approval of generic drugs in Indonesia and Vietnam is quite similar concerning the regulations framed by their respective drug regulatory authorities. In Malaysia, Drug Control Authority accepts only web-based online submissions. The applicant for product registration must be registered with the Malaysian Register of Business (ROB) and should become a quest member at the NPCB website.Conclusion: From our studies relevant to the regulatory perspectives, it is concluded that Malaysia had well-framed drug regulations for generic drugs compared to Indonesia and Vietnam.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
DS, S., CR, S., V, A. N., & MP, G. (2022). Generic Drugs Regulations and Registration in Indonesia, Malaysia and Vietnam: A Drug Regulatory Case Study. Journal of Young Pharmacists, 14(1), 33-36. https://doi.org/10.5530/jyp.2022.14.7
Copyright and licence
© 2022 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
